The study identifies new cell types within the skin that are targeted by EBOV during infection and ... Paving the Way for Antivirals Against Ebola Virus and Its Deadly Relatives Sep. 17 ...
The Ebola virus (EBOV) is notorious for causing severe hemorrhagic fever in humans, and its matrix protein, VP40, plays a crucial role in the virus's ability to assemble and bud from host cells.
LONDON, GREATER LONDON, UNITED KINGDOM, January 25, 2025 /EINPresswire / -- The ebanga market size has seen significant historical compound annual growth, growing from millions in 2024 to a higher ...
ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...
President Donald Trump eliminated Biden executive orders on insurance, drug pricing and artificial intelligence.
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
Organic growth amounted to 3.9%, of which volume accounted for 1.7% and price/mix 2.2%. Excluding restructuring, organic growth increased 4.9%.EBITA decreased 1% to SEK ...
After 14 years with the Group, and almost ten years as president and CEO, Magnus Groth has today informed the Board of Directors of Essity Aktiebolag (publ) that he has decided to step down as CEO and ...
Hypertension Diagnostics (OTCMKTS:HDII – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will ...
His team at HHS has paused critical communications and meetings, right as public health officials are worried about bird flu.
Appointment of José Antonio Alas brings more than 30 years of biotech expertise, including global business development, ...
AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.